MYRIAD GENETICS INC (MYGN:NASDAQ)
$6.18 -0.01 (-0.1616%)
Analysed MYRIAD GENETICS INC (MYGN:NASDAQ) News Sources
1 Cash-Burning Stock with Promising Prospects and 2 Facing Headwinds
05-06-2026
yahoo.com
Should You Add Myriad Genetics Stock to Your Portfolio Right Now?
09-06-2026
yahoo.com
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
23-06-2026
yahoo.com
Why Is Myriad Genetics (MYGN) Stock Rocketing Higher Today
24-06-2026
yahoo.com
Myriad (MYGN) Soars 8.3%: Is Further Upside Left in the Stock?
29-06-2026
yahoo.com
Spotting Winners: Myriad Genetics (NASDAQ:MYGN) And Therapeutics Stocks In Q1
30-06-2026
yahoo.com
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
01-07-2026
yahoo.com
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
02-07-2026
yahoo.com
Is This the Right Time to Hold MYGN Stock in Your Portfolio?
15-07-2026
yahoo.com
AWHL vs. MYGN: Which Women's Health Diagnostics Stock is Better Now?
17-07-2026
yahoo.com
What is the current price of MYRIAD GENETICS INC (MYGN:NASDAQ)?
The current price of MYRIAD GENETICS INC (MYGN:NASDAQ) is $6.18.
MYRIAD GENETICS INC (MYGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of MYRIAD GENETICS INC (MYGN:NASDAQ) since the previous trading day is $-0.01.
MYRIAD GENETICS INC (MYGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of MYRIAD GENETICS INC (MYGN:NASDAQ) since the previous trading day is -0.1616%.
What is the most recent average sentiment score for MYRIAD GENETICS INC (MYGN:NASDAQ)?
The most recent average sentiment score for MYRIAD GENETICS INC (MYGN:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for MYRIAD GENETICS INC (MYGN:NASDAQ)?
The most recent sentiment for MYRIAD GENETICS INC (MYGN:NASDAQ) is .
SEC-8K** Filing Available For MYRIAD GENETICS INC (MYGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.